Mini-Oral Abstract: Adventures with immunosuppression
Friday September 19, 2025 from 10:00 to 11:00
MOA 5
Moderators
Lectures
  • 211.1 Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants
    Dr. Maral Baghai Arassi, Germany
  • 211.2 The Induction Conundrum: To Study the Impact of Induction Immunosuppression on the Incidence of Rejections and Infections, Graft and Patient Survival in Pediatric Kidney Transplant Recipients Retrospectively
    Dr. Nayan Ashok Chaudhari, India
  • 211.3 Effects of calcineurin inhibitors on renal function in paediatric liver transplant recipients at a tertiary academic hospital
    Dr. Karabo Lesley K L Leotlela, South Africa
  • 211.4 A five-year retrospective review of using a steroid minimisation national protocol at a single centre: Is mycophenolate mofetil less tolerated in the younger transplant recipient?
    Dr. Jennifer R Martin, United Kingdom
  • 211.5 Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development, in Paediatric Kidney Transplant Recipients (KTR): A Retrospective Cohort from a single Indian Centre
    Dr. Kinnari Vala, India
  • 211.6 Immunosuppressant withdrawal and characteristics of regulatory T cells in allograft histology among pediatric liver transplantation recipients
    Prof. Kai Wang, People's Republic of China
  • 211.7 Alternative, Low-Cost Monitoring of CD3 cell depletion following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients
    Abanti Chaudhuri, United States
  • 211.8 Pubertal stage specific changes in T-cell subpopulations in healthy individuals and pediatric kidney transplant recipients
    Dr. Femke Vrieling-Prince, Netherlands

© 2025 IPTA 2025